Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Transforming Growth Factor Beta 1 (TGF-β1) pathway is a highly conserved signaling cascade that regulates a wide array of cellular processes in both developing embryos and adult organisms. These processes include cell growth, differentiation, migration, apoptosis (programmed cell death), and maintenance of cellular homeostasis. TGF-β1 also plays critical roles in immune regulation, vascular system function, embryonic development, wound healing, connective tissue formation, and the prevention of tumor growth. The pathway signals through a heterotetrameric receptor complex composed of type I (TGFBR1/ALK5) and type II (TGFBR2) serine/threonine kinase receptors, leading to the activation of SMAD proteins and subsequent regulation of gene expression. Dysregulation of the TGF-β1 pathway is implicated in various diseases, including cancer and fibrosis.
Modulation of TGF-β1 signaling can be achieved through various mechanisms, including blocking ligand-receptor interaction, inhibiting downstream signaling molecules (e.g., SMADs, MAPKs), or modulating the activity of TGF-β1 activators.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transforming Growth Factor Beta 1 Pathway (TGF-β1 Pathway).